OLD Category: pan cancer panels

Tumor Infiltrating Lymphocytes Signature as a New Pan-Cancer Predictive Biomarker of Anti PD-1/PD-L1 Efficacy

• Ballot E, Ladoire S, Routy B, Truntzer C, Ghiringhelli F

Expression, intracellular localization, and mutation of EGFR in conjunctival squamous cell carcinoma and the association with prognosis and treatment

• Sakai A, Tagami M, Kakehashi A, Katsuyama-Yoshikawa A, Misawa N, Wanibuchi H, Azumi A, Honda S

Changes in peripheral and local tumor immunity after neoadjuvant chemotherapy reshape clinical outcomes in patients with breast cancer

• Axelrod ML, Nixon M, Gonzalez-Ericsson PI...Mayer IA, Salgado R, Balko JM

Extracellular Vesicles from Pseudomonas aeruginosa Suppress MHC-Related Molecules in Human Lung Macrophages

• Armstrong DA, Lee MK, Hazlett HF, Dessaint JA, Mellinger DL, Aridgides DS, Hendricks GM, Abdalla MAK, Christensen BC, Ashare A

Toll-Like Receptor 4 Expression on Lymphoma Cells Is Critical for Therapeutic Activity of Intratumoral Therapy With Synthetic TLR4 Agonist Glucopyranosyl Lipid A

• Lu H, Betancur A, Chen M, ter Meulen JH

Combining BRAF inhibition with oncolytic herpes simplex virus enhances the immune-mediated antitumor therapy of BRAF-mutant thyroid cancer

• Crespo-Rodriguez E, Bergerhoff K, Bozhanova G...Melcher AA, Harrington KJ, Pedersen M

Epigenetic Silencing of LMX1A Contributes to Cancer Progression in Lung Cancer Cells

• Wu TH, Chang SY, Shih YL, Chian CF, Chang H, Lin YW

Small molecule AZD4635 inhibitor of A2AR signaling rescues immune cell function including CD103+ dendritic cells enhancing anti-tumor immunity

• Borodovsky A, Barbon CM, Wang Y...Fawell S, Schuller AG, Mele DA

Prognostic value of novel immune-related genomic biomarkers identified in head and neck squamous cell carcinoma

• Yao Y, Yan Z, Lian S, Wei L, Zhou C, Feng D, Zhang Y, Yang J, Li M, Chen Y

Preferentially expressed antigen in melanoma as a novel diagnostic marker differentiating thymic squamous cell carcinoma from thymoma

• Taniguchi Y, Ishida M, Saito T, Ryota H, Utsumi T, Maru N, Matsui H, Hino H, Tsuta K, Murakawa T

MOLECULAR DETERMINANTS OF THYROID NODULES WITH INDETERMINATE CYTOLOGY AND RAS MUTATIONS

• Hernandez-Prera J, Valderrabano P, Creed J...Caudell J, Gerke TA, Chung CH

Dendritic cell vaccination and CD40-agonist combination therapy licenses T cell-dependent antitumor immunity in a pancreatic carcinoma murine model

• Lau SP, van Montfoort N, Kinderman P...van Hall T, Dammeijer F, van Eijck CHJ